title: Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.
authors.affiliation: Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA. htilson@email.unc.edu
authors.forename: Hugh H
authors.initials: HH
authors.lastname: Tilson
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D017063:Outcome Assessment, Health Care; D011247:Pregnancy; D011322:Primary Prevention; D012042:Registries; D012308:Risk Management
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine